These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10194076)

  • 21. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.
    Tasker SA; O'Brien WA; Treanor JJ; Weiss PJ; Olson PE; Kaplan AH; Wallace MR
    Vaccine; 1998; 16(9-10):1039-42. PubMed ID: 9682356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine.
    Greenbaum E; Furst A; Kiderman A; Stewart B; Levy R; Schlesinger M; Morag A; Zakay-Rones Z
    J Med Virol; 2001 Sep; 65(1):178-84. PubMed ID: 11505461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virosomal influenza vaccine: a safe and effective influenza vaccine with high efficacy in elderly and subjects with low pre-vaccination antibody titers.
    de Bruijn IA; Nauta J; Gerez L; Palache AM
    Virus Res; 2004 Jul; 103(1-2):139-45. PubMed ID: 15163502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination and HIV-1 replication during highly active antiretroviral therapy.
    Kroon FP; Beersma MF; Kroes AC; Groeneveld PH; van Dissel JT
    AIDS; 1999 Jan; 13(1):135-6. PubMed ID: 10207556
    [No Abstract]   [Full Text] [Related]  

  • 25. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 26. Changing perspective on immunization against influenza.
    Johansson BE; Brett IC
    Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compromised B cell responses to influenza vaccination in HIV-infected individuals.
    Malaspina A; Moir S; Orsega SM; Vasquez J; Miller NJ; Donoghue ET; Kottilil S; Gezmu M; Follmann D; Vodeiko GM; Levandowski RA; Mican JM; Fauci AS
    J Infect Dis; 2005 May; 191(9):1442-50. PubMed ID: 15809902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vaccination against influenza in the elderly. Experience with adjuvant vaccines].
    Baldo V; Menegon T; Buoro S; Scalici C; Vesco A; Perale S; Boato W; Carletti M; Bonello C; Dalla Costa D; Trivello R
    Ann Ig; 1999; 11(5):369-74. PubMed ID: 10596424
    [No Abstract]   [Full Text] [Related]  

  • 29. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avian influenza. 'Pandemic vaccine' appears to protect only at high doses.
    Enserink M
    Science; 2005 Aug; 309(5737):996. PubMed ID: 16099954
    [No Abstract]   [Full Text] [Related]  

  • 31. Influenza vaccination does not accelerate HIV infection.
    AIDS Read; 2001 Jan; 11(1):26. PubMed ID: 11215081
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
    Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
    J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?
    Beyer WE; Palache AM; Lüchters G; Nauta J; Osterhaus AD
    Virus Res; 2004 Jul; 103(1-2):125-32. PubMed ID: 15163500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use.
    Hehme N; Engelmann H; Kuenzel W; Neumeier E; Saenger R
    Virus Res; 2004 Jul; 103(1-2):163-71. PubMed ID: 15163505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa.
    Brokstad KA; Eriksson JC; Cox RJ; Tynning T; Olofsson J; Jonsson R; Davidsson A
    J Infect Dis; 2002 Apr; 185(7):878-84. PubMed ID: 11920311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
    Michiels B; Philips H; Coenen S; Denekens J; Van Royen P
    Vaccine; 2006 Apr; 24(16):3145-52. PubMed ID: 16490288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis.
    Elkayam O
    Clin Dev Immunol; 2006; 13(2-4):349-51. PubMed ID: 17162376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P; Kositanont U; Sornsathapornkul P; Tothong P; Kanyok R; Thongcharoen P
    Vaccine; 2007 Jan; 25(4):659-63. PubMed ID: 17011678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.